Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension, October 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 166 articles: HTML format

Single Articles

1. KABALAK PA, Soyler Y, Cengiz TI, Celik M, et al
   Management of Pulmonary Hypertension in Interstitial Lung Disease Without Access to Inhaled Treprostinil: A Case Series from a Resource-Limited Setting.
   Am J Med Sci. 2026 Oct 2:S0002-9629(26)00366-6. doi: 10.1016/j.amjms.2026.
   PubMed    
   Abstract available
   
   

2. DAN Y, Xu G, Chen H, Li H, et al
   Safety assessment of ambrisentan based on the FDA Adverse Event Reporting System.
   Medicine (Baltimore). 2026;105:e50893.
   PubMed    
   Abstract available
   
   

3. KANG MK, Kim KI, Ryu J, Shin DG, et al
   Echocardiographic factors suggestive of pulmonary hypertension in patients with mediastinal tumors: A single-center observational study.
   Medicine (Baltimore). 2026;105:e50924.
   PubMed    
   Abstract available
   
   

4. FERNANDES GARCIA MV, Lahm T
   HIV-associated pulmonary arterial hypertension: improving survival despite persistent treatment gaps - a systematic review and meta-analysis.
   AIDS. 2026;40:1773-1776.
   PubMed    
   Abstract available
   
   

5. BILEN MM, Mese T, Yilmazer MM, Vuran G, et al
   Investigation of the Effects of Switching from Bosentan to Macitentan in Pediatric Pulmonary Hypertension Patients.
   Sisli Etfal Hastan Tip Bul. 2026;60:405-411.
   PubMed    
   Abstract available
   
   

6. PRINCIBA DB, Kulkarni RR
   Comment on "Artificial intelligence enhanced contemporary pulmonary hypertension care".
   Am Heart J Plus. 2026;70:100893.
   PubMed    
   
   
   

7. VELLA A, Muller J, Omuralieva A, Titz A, et al
   Effects of high-dose supplemental oxygen therapy on pulmonary haemodynamics at 3250 m in high-altitude residents at risk for pulmonary hypertension.
   BMJ Open Respir Res. 2026;13:e004376.
   PubMed    
   Abstract available
   
   

8. SAEED M, Sabanci R, Ghumman GM, Tahir A, et al
   BATMAN-Assisted Valve-in-Valve TMVR With Planned Hemodynamic Support in Severe Pulmonary Hypertension.
   JACC Case Rep. 2026;31:110039.
   PubMed    
   Abstract available
   
   

9. GILLMEYER KR, Vimalananda VG, Sun L, Rinne ST, et al
   Resources Available for Pulmonary Hypertension Care Across Veterans Health Administration Medical Centers: Results From a Multicenter Survey.
   Med Care. 2026 Oct 1. doi: 10.1097/MLR.0000000000002386.
   PubMed    
   Abstract available
   
   

10. ARUN BABU T, Sharmila V
    Sildenafil and fetomaternal outcomes in pregnancy-associated pulmonary hypertension.
    Ann Pediatr Cardiol. 2026;19:623-624.
    PubMed    
    
    
    

11. OLIVEIRA AC, da Silva F, Zhang Y, Alves MD, et al
    TREM2 Orchestrates Myeloid Cell Programming and Immune Dysregulation in Pulmonary Hypertension.
    bioRxiv [Preprint]. 2026 Sep 24:2026.09.18.752808.
    PubMed    
    Abstract available
    
    

12. VAN LEENT MMT, St Hillaire T, Sivalokanathan S, Morita H, et al
    PET Imaging in Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2026 Oct 1. doi: 10.1161/ATVBAHA.126.324761.
    PubMed    
    Abstract available
    
    

13. GONG X, Wang Y, Kang S, Zhang Z, et al
    Sinapine thiocyanate (ST) ameliorates endothelial cell dysfunction by targeting chloride intracellular channel 4 (CLIC4) to treat hypoxia-induced pulmonary hypertension.
    Br J Pharmacol. 2026 Sep 30. doi: 10.1111/bph.70676.
    PubMed    
    Abstract available
    
    

14. GELEN MA, Yildiz G, Bolayir HA, Karasu M, et al
    Platelet-Albumin-Bilirubin Index for Predicting Hospitalization and Mortality in Pulmonary Hypertension.
    Circ J. 2026 Sep 30. doi: 10.1253/circj.CJ-26-0436.
    PubMed    
    Abstract available
    
    

15. BERTOLETTI L, Chapelle C
    Extended anticoagulation with edoxaban in chronic thromboembolic pulmonary hypertension: reassuring real-world data, but can direct oral anticoagulants systematically replace vitamin K antagonists?
    J Thromb Haemost. 2026;24:3450-3452.
    PubMed    
    
    
    

16. TANG W, Cai J, Zhang S, Li Y, et al
    Preliminary study of individualized therapy for ventricular septal defect with severe pulmonary arterial hypertension.
    Clin Exp Hypertens. 2026;48:2734004.
    PubMed    
    Abstract available
    
    

17. GOLDHABER SZ, Rashedi S, Pfeferman M, Amalan C, et al
    Alert-Based Computerized Decision Support to Increase Screening for Pulmonary Hypertension after Pulmonary Embolism: The CTEPH-DETECT Trial.
    Am J Med. 2026 Sep 30:S0002-9343(26)00700-X. doi: 10.1016/j.amjmed.2026.
    PubMed    
    Abstract available
    
    

18. PETROVIC A, Pak O, Schneider JN, Ewert J, et al
    Role of carbonic anhydrases 9 and 12 in hypoxia and non-hypoxia associated pulmonary hypertension.
    Am J Respir Cell Mol Biol. 2026 Sep 30:aanag182. doi: 10.1093.
    PubMed    
    Abstract available
    
    

19. SHEIKH N, Ahmed CM, Arzu J, Jamali Z, et al
    Outcome of 30 Pregnant Women with Pulmonary Hypertension at Bangladesh Medical University, Dhaka, Bangladesh.
    Mymensingh Med J. 2026;35:1172-1179.
    PubMed    
    Abstract available
    
    

20. FUENTES-MENDOZA J, Sernaque-Paz M, Cruz-Riquelme D, Zavaleta-Corvera C, et al
    Sildenafil in bronchopulmonary dysplasia-associated pulmonary hypertension: developmental and translational insights.
    Pediatr Res. 2026 Sep 29. doi: 10.1038/s41390-026-05480.
    PubMed    
    Abstract available
    
    

21. BAE SS, Rivero Gallegos D, Bozan F, Sambataro G, et al
    Pulmonary hypertension in anti-synthetase syndrome: prevalence, comparative risk across autoimmune diseases, and impact on survival.
    Rheumatology (Oxford). 2026 Sep 29:keag543. doi: 10.1093.
    PubMed    
    Abstract available
    
    

22. ASANO R, Kiko T, Kawabata T, Sano Y, et al
    Real-world analysis on hemodynamic effectiveness and adverse events of selexipag in pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2026;20:17534666261484754.
    PubMed    
    Abstract available
    
    

23. CHEN Z, He Z, Liu X, Chen Y, et al
    S100A9 Inhibition Mediates Aerobic Exercise Benefits in Pulmonary Hypertension.
    J Am Heart Assoc. 2026 Sep 29:e049578. doi: 10.1161/JAHA.125.049578.
    PubMed    
    Abstract available
    
    

24. LIU B, Yan W, Zhang H, Luo Q, et al
    Novel hepatic function-based prognostic prediction model for pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2026;20:17534666261493712.
    PubMed    
    Abstract available
    
    

25. HAAS SO, Benjamin N, Shaukat M, Schneider MA, et al
    Impaired BMPR2 signalling across pulmonary hypertension subgroups: a multicentre study.
    ERJ Open Res. 2026;12:01644-2025.
    PubMed    
    Abstract available
    
    

26. RAZA A, Rali P, Naranjo MT, Gayen S, et al
    Can Quantitative CT Scan Analysis of Pulmonary Parenchymal and Vascular Characteristics Help to Differentiate Among Various Phenotypes of COPD Associated With Pulmonary Hypertension?
    CHEST Pulm. 2026;4:100244.
    PubMed    
    Abstract available
    
    

27. ZAHRA A, Shabahat H, Rizvi SVZ, Khan WI, et al
    Trends in mortality with pulmonary hypertension and diabetes mellitus as contributing causes of death among U.S. Adults, 1999-2024.
    J Diabetes Metab Disord. 2026;25:271.
    PubMed    
    Abstract available
    
    

28. GONZALEZ T, Simpkin CT, Dias Maia P, Archambault JL, et al
    Flow versus resistance: hemodynamic phenotyping of pulmonary hypertension in infants with shunts and concurrent lung disease.
    Front Pediatr. 2026;14:1880632.
    PubMed    
    Abstract available
    
    

29. JUTANT EM, Delarche B, Croquette M, Beurnier A, et al
    Pulmonary vascular reactivity in severe pulmonary hypertension associated with COPD.
    ERJ Open Res. 2026;12:01606-2025.
    PubMed    
    Abstract available
    
    

30. LIU J, Wang Y
    Clinical Value of Real-Time Three-Dimensional Echocardiography for Evaluating Right Ventricular Structure and Function in Patients With Pulmonary Hypertension Across Different Echocardiographic Pulmonary Artery Systolic Pressure Strata.
    Echocardiography. 2026;43:e70621.
    PubMed    
    Abstract available
    
    

31. WANG Y, Wu Q, Zhang X, Sun Z, et al
    High-Frequency Oscillatory Ventilation Combined With Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Single-Center Randomized Clinical Trial.
    Can Respir J. 2026;2026:e8717590.
    PubMed    
    Abstract available
    
    

32. SHRIVASTAV A, Tivaskar S, Luharia A, Gomase S, et al
    Echocardiographic assessment of pulmonary hypertension: a hierarchical interpretive framework for clinical decision-making and echo laboratory practice.
    Echo Res Pract. 2026;13:35.
    PubMed    
    Abstract available
    
    

33. AHMADI F, Parnia R, Astani B, Keshmiri MS, et al
    Successful Pregnancy in Chronic Obstructive Pulmonary Hypertension Secondary to Pulmonary and Cardiac Hydatid Cysts: A Case Report.
    Res Heart Yield Transl Med. 2026;21:111-115.
    PubMed    
    Abstract available
    
    

34. LADIB A, Ladib J, Bouzuita B, Chamtouri I, et al
    Maternal and neonatal outcomes in pregnant women with pulmonary hypertension: A retrospective study from a Tunisian tertiary center (2013-2023).
    Int J Obstet Anesth. 2026;68:105223.
    PubMed    
    Abstract available
    
    

35. KANAKARAJU K, Paulose A, Ilangovan R, Rangabashyam SK, et al
    Late Presentation of Lutembacher Syndrome with Severe Pulmonary Hypertension and Tricuspid Regurgitation Complicated by Lower Respiratory Tract Infection in an Elderly Female: A Fatal Case Report.
    Ann Afr Med. 2026 Sep 25. doi: 10.4103.
    PubMed    
    Abstract available
    
    

36. SKOCZYLAS I, Piegza J, Waligora M, Skoczylas M, et al
    The Impact of Balloon Pulmonary Angioplasty (BPA) on Changes in the Liver Fibrosis Index (FIB-4 Index) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
    J Clin Med. 2026;15:7251.
    PubMed    
    Abstract available
    
    

37. AKHMEDOVA N, Kholov G, Ochilov U, Shonazarova N, et al
    Airway and Gut Dysbiosis, Infectious Exacerbations and Pulmonary Vascular Remodelling in COPD-Associated Pulmonary Hypertension: Microbial Mechanisms, Causal Uncertainty and Therapeutic Implications.
    Microorganisms. 2026;14:1954.
    PubMed    
    Abstract available
    
    

38. ATCHISON B, Byars S, Prestes PR, Myers M, et al
    Integrated Analysis of Rat Pulmonary Hypertension Datasets Identifies Candidate circRNA Networks in Hypoxia-Exposed Pulmonary Artery Tissue.
    Int J Mol Sci. 2026;27:8195.
    PubMed    
    Abstract available
    
    

39. LUCERO MJ, Nozik E, Hassell K, Irwin DC, et al
    Extracellular Hemoglobin, Hypoxia, and Macrophage-Mediated Pulmonary Vascular Remodeling in Hemolytic Disease.
    Int J Mol Sci. 2026;27:8170.
    PubMed    
    Abstract available
    
    

40. WANG X, Jiang X, Li Z, Wang Y, et al
    Exploring the Toxicological Impacts of DOTP Exposure on Pulmonary Arterial Hypertension via Network Toxicology, Virtual Knockout, Molecular Docking and Experimental Validation.
    Int J Mol Sci. 2026;27:8064.
    PubMed    
    Abstract available
    
    

41. AHMED F, Zulfiqar A, Ali R, Shah SS, et al
    Correlation of Echocardiographic Right Ventricular Functional Parameters with CMR-Derived Right Ventricular Ejection Fraction in Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
    Diagnostics (Basel). 2026;16:2899.
    PubMed    
    Abstract available
    
    

42. STOICA CI, Araniciu C, Ionut IA, Stana A, et al
    Type I Interferon Emerges as the Reproducible Core of a Shared Mitochondrial-Immune Transcriptomic Signature in Pulmonary Arterial Hypertension and Bipolar Disorder.
    Genes (Basel). 2026;17:1147.
    PubMed    
    Abstract available
    
    

43. YANG S, Li L, Zhang J, Qiao X, et al
    Glutathione Redox Changes in Pulmonary Arterial Blood After Remote Ischemic Conditioning in Pulmonary Hypertension: A Single-Arm Pilot Study.
    Antioxidants (Basel). 2026;15:1203.
    PubMed    
    Abstract available
    
    

44. ANDERSEN MP, Kristensen MH, Hansen ESS, Schulte RF, et al
    Correlating Pulmonary Hemodynamics With HP (129)Xe Dissolved-Phase MRSI in a Controlled Porcine Intervention Study.
    Magn Reson Med. 2026;96:2588-2600.
    PubMed    
    Abstract available
    
    

45. LIU A, He P, Du J, Ma R, et al
    Quantitative lung perfusion in pulmonary vascular diseases: a comparative study of phase-resolved functional lung MRI and ventilation/perfusion SPECT.
    Eur J Radiol. 2026;204:113095.
    PubMed    
    Abstract available
    
    

46. WUYTS EWV, Van Horebeek I, Devlieger R
    Prenatal Presentation of Congenital Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins: A Case Initially Suspected as Posterior Urethral Valves.
    J Paediatr Child Health. 2026 Jul 11. doi: 10.1111/jpc.70502.
    PubMed    
    Abstract available
    
    

47. MIURA M, Tanaka S, Aihara R, Yamamoto S, et al
    Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs.
    Br J Clin Pharmacol. 2026;92:3611-3621.
    PubMed    
    Abstract available
    
    

48. ZHANG Y, Li Y, Mao Y, Hu X, et al
    Supracardiac Total Anomalous Pulmonary Venous Connection with Left Main Bronchial Compression in an Infant.
    World J Pediatr Congenit Heart Surg. 2026;17:863-866.
    PubMed    
    Abstract available
    
    

49. HAGHEBAERT M, Varsos P, Meiburg R, Vignon-Clementel I, et al
    A comparative study of lumped heart models for personalized medicine through sensitivity and identifiability analysis.
    J Physiol. 2026;604:8167-8200.
    PubMed    
    Abstract available
    
    

50. PASQUINUCCI M, Scaglione M, Mezzalira S, Bonsembiante L, et al
    Addressing micronutrient deficiencies and vitamin metabolism disorders in pediatric pulmonary hypertension: a strategic proposal for low- and middle-income countries.
    Front Cardiovasc Med. 2026;13:1900356.
    PubMed    
    Abstract available
    
    

51. ALQAHTANI A, Alzubi F, Obeid D, Alhamlan F, et al
    SARS-CoV-2 infection and two-year longitudinal clinical trajectory in pulmonary hypertension: a single-center retrospective exploratory cohort study.
    Front Public Health. 2026;14:1901917.
    PubMed    
    Abstract available
    
    

52. MARTIN E, Wiggen KE, Williams K, Masseau I, et al
    Developmental lung disease with associated pulmonary hypertension in a Sphynx kitten.
    JFMS Open Rep. 2026;12:20551169261462693.
    PubMed    
    Abstract available
    
    

53. FUJIWARA T, Lu VI, Frank BS, Simpkin C, et al
    Robust Approach to Measure Time-Resolved Septal Curvature in Pediatric Pulmonary Hypertension Patients Using Standard Short-Axis Ventricular Volume Contours: A Retrospective, Cross-Sectional Study.
    J Cardiovasc Magn Reson. 2026 Oct 8:102807. doi: 10.1016/j.jocmr.2026.102807.
    PubMed    
    Abstract available
    
    

54. ZHANG H, Ou G, Yi J, Huang Z, et al
    Tryptophan metabolism: a potential link between the gut microbiota and pulmonary vascular remodeling in pulmonary hypertension.
    Front Cell Infect Microbiol. 2026;16:1960734.
    PubMed    
    Abstract available
    
    

55. BAJPAI J, Pradhan A, Ahmad MK, Kant S, et al
    Estimation of Endothelin Levels in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension: A Clinical Insight.
    Ann Afr Med. 2026 Oct 7. doi: 10.4103.
    PubMed    
    Abstract available
    
    

56. AZIZ S, Roy J, Whalen E, Varghese NP, et al
    The Role of Specialty Pediatric Palliative Care in Pulmonary Hypertension: A Case Series.
    J Palliat Med. 2026 Oct 7:10966218261494685. doi: 10.1177/10966218261494685.
    PubMed    
    Abstract available
    
    

57. ALBULUSHI A, Al Rashdi T, Al-Farhan H
    Pulmonary Hypertension Classification Revisited: Actionable Simplicity vs Real-World Complexity.
    JACC Asia. 2026;6.
    PubMed    
    
    
    

58. CHEN X, Zhang Z, Lan X, Chen W, et al
    Pulmonary Artery Denervation for Persistent Pulmonary Hypertension After Transcatheter Mitral Edge-to-Edge Repair: A Pilot Study and First Application in the Post M-TEER Setting.
    Pulm Circ. 2026;16:e70404.
    PubMed    
    Abstract available
    
    

59. YOON J, Lee SW, Park YB, Song JJ, et al
    Cause-specific outcomes in systemic sclerosis-associated, systemic lupus erythematosus-associated, and idiopathic pulmonary hypertension with significant pre-capillary components: a competing risk analysis.
    Clin Rheumatol. 2026 Oct 6. doi: 10.1007/s10067-026-08464.
    PubMed    
    Abstract available
    
    

60. MORGAN C, Calder A, Prapa M, Sekar T, et al
    Variant Class-Specific Phenotypes and Outcomes in Pediatric TBX4-Associated Pulmonary Hypertension.
    Pediatr Pulmonol. 2026;61:e71857.
    PubMed    
    Abstract available
    
    

61. NAZARETH KR, Jamileh E, Muhammad F, Farooq O, et al
    Diagnostic performance of artificial intelligence-enabled electrocardiography for pulmonary hypertension: a systematic review and meta-analysis.
    Eur Heart J Digit Health. 2026;7:ztag143.
    PubMed    
    Abstract available
    
    

62. BAHADORAN S, Torabi AH, Hassanpour H
    Melatonin reduces intestinal oxidative damage in broilers with pulmonary hypertension under high-altitude and cold stress.
    Vet Anim Sci. 2026;34:100847.
    PubMed    
    Abstract available
    
    

63. YUAN M, Chen P, Zhan Z, Ruan J, et al
    The Role of Exosomes in Pulmonary Hypertension: Mechanisms and Therapeutic Potential.
    Int J Nanomedicine. 2026;21:644296.
    PubMed    
    Abstract available
    
    

64. VIRSINSKAITE R, Brown JT, Kotecha T, Bower D, et al
    Validation of a Novel, Low-Cost, Portable MRI-Compatible Exercise Device in Healthy Volunteers and Patients With Pulmonary Hypertension.
    NMR Biomed. 2026;39:e70412.
    PubMed    
    Abstract available
    
    

65. MENG Q, Chan SY
    PlGF in pulmonary hypertension: addressing the angiogenesis paradox via immune remodeling.
    Cardiovasc Res. 2026 Oct 3:cvag224. doi: 10.1093.
    PubMed    
    
    
    

66. KLOSE H, Roitenberg A, Kronberg K
    Factors influencing treatment decisions in patients with pulmonary arterial hypertension.
    Dtsch Med Wochenschr. 2026 Sep 9. doi: 10.1055/a-2893-7266.
    PubMed    
    Abstract available
    
    

67. WEATHERILL JW, Labazi H, Denver N, Simpson JP, et al
    Estrogenic profiles in lungs from a rat model of pulmonary arterial hypertension measured by liquid chromatography triple quadrupole mass spectrometry.
    Talanta. 2027;312.
    PubMed    
    Abstract available
    
    

68. NAKAYAMA Y, Eguchi S
    Response to: Comment on: The renin-angiotensin system in models of pulmonary arterial hypertension vs primary hypertension.
    Hypertens Res. 2026;49:2911-2912.
    PubMed    
    Abstract available
    
    

69. OPATRIL L, Mojica-Pisciotti ML, Panovsky R, Machal J, et al
    Quantitative CMR-derived pulmonary circulation imaging biomarkers in recent-onset dilated cardiomyopathy associated with pulmonary hemodynamics and clinical improvement.
    BMC Med Imaging. 2026;26:514.
    PubMed    
    Abstract available
    
    

70. BING Y, Yuan W, Liang L, Li J, et al
    Alterations in the fecal virome and bacteriome-virome interplay in IPAH.
    Respir Res. 2026;27:382.
    PubMed    
    Abstract available
    
    

71. NUNES MCP, Blum J, Ferrari TCA
    Cardiac involvement in parasitic infections.
    Eur Heart J. 2026;47:5458-5482.
    PubMed    
    Abstract available
    
    

72. SCHUARZBERG P, Princic V, Barakian BF, Raimondi R, et al
    [Polyclonal hypergammaglobulinemia, pulmonary hypertension, hyperviscosity and coagulopathy in a patient with Rhupus].
    Medicina (B Aires). 2026;86:1344-1348.
    PubMed    
    Abstract available
    
    

73. BOYARSKAYA N, Kuchur P, Docshin P, Skortsanu O, et al
    Transcriptomic Profiling of Adherent Cells Isolated from Wedged Pulmonary Arterial Blood of Patients with Pulmonary Arterial Hypertension Reveals a Predominantly Myeloid Rather than Endothelial Phenotype.
    Int J Mol Sci. 2026;27:8799.
    PubMed    
    Abstract available
    
    

74. FLOAREA G, Assi N, Ismail M, Gattis A, et al
    Development of a Novel Nanoparticle Targeting Endothelial Cells from Patients with Pulmonary Arterial Hypertension.
    Molecules. 2026;31:3511.
    PubMed    
    Abstract available
    
    

75. ALGHAMDI K, Hokmabadi A, van der Geest R, Garg P, et al
    Automated CMR Quantification of Pulmonary Artery Size-Based and Slow-Flow Metrics in Pulmonary Hypertension.
    Diagnostics (Basel). 2026;16:3257.
    PubMed    
    Abstract available
    
    

76. AHMED F, Zulfiqar A, Bhadra TK, Sabah NU, et al
    Diagnostic Accuracy of Machine Learning-Enhanced Methods for Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
    Diagnostics (Basel). 2026;16:3106.
    PubMed    
    Abstract available
    
    

77. MOLLA NW, Sewaralthahab S, Alotaibi RA, Alymni AA, et al
    CT Features of Sickle Cell Disease-Associated Pulmonary Hypertension.
    J Clin Med. 2026;15:7611.
    PubMed    
    Abstract available
    
    

78. EROUME A EGOM E, Mfopa A, Ibrahim N, Celestin M, et al
    Natriuretic Peptide Receptor-C (NPR3) in Pulmonary Hypertension Associated with Chronic Lung Disease: A PRISMA-ScR Scoping Review of Diagnostic, Prognostic, Mechanistic, and Therapeutic Evidence.
    J Clin Med. 2026;15:7429.
    PubMed    
    Abstract available
    
    

79. KRAMER M, Kramer T
    A Machine Learning Framework for Predicting Functional Status and Estimating Health Care Costs in Pulmonary Arterial Hypertension: Retrospective Cohort Study.
    JMIR Med Inform. 2026;14:e97372.
    PubMed    
    Abstract available
    
    

80. ZHANG Z, Duo M, Ji X, Zou B, et al
    Prior Venous Thromboembolism Defines Distinct Genetic and Molecular Phenotypes in Chronic Thromboembolic Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2026 Oct 15. doi: 10.1161/ATVBAHA.126.325037.
    PubMed    
    Abstract available
    
    

81. LISK C, Cendali F, Westover N, Swindle D, et al
    Macrophages Contribute to Pulmonary Hypertension Associated With Sickle Cell Disease.
    Pulm Circ. 2026;16:e70413.
    PubMed    
    Abstract available
    
    

82. MARQUET Y, Jacqmin S, Fessler J, Sage E, et al
    Right Ventricular Stroke Work Index and Its Prognostic Value in a Lung Transplant Population With Group 3 Pulmonary Hypertension.
    J Transplant. 2026;2026:1628090.
    PubMed    
    Abstract available
    
    

83. FANG X, Zhang H, Chen Y, Zeng Q, et al
    Comparison of Clinical, Hemodynamic and Imaging Profiles Between Isolated Pulmonary Vasculitis and Chronic Thromboembolic Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70421.
    PubMed    
    Abstract available
    
    

84. FATHIEH F, Nemati N, Burton T, Gillins HR, et al
    Beyond detection: developing probabilistic hemodynamic phenotyping after a positive point-of-care pulmonary hypertension test.
    Front Digit Health. 2026;8:1955810.
    PubMed    
    Abstract available
    
    

85. DMUCHOWSKA DA, Ptaszynska K, Konopinska J, Kaminski K, et al
    Interocular symmetry of retinal and choroidal OCT parameters in precapillary pulmonary hypertension: a brief research report.
    Front Med (Lausanne). 2026;13:1788867.
    PubMed    
    Abstract available
    
    

86. O'NEIL MJ, Sleeper LA, Varghese NP, Critser PJ, et al
    Antithrombotic Therapy Use in Children With Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70418.
    PubMed    
    Abstract available
    
    

87. YANG HW, Wang J, Ji H, Gui L, et al
    Prevalence and factors associated with pulmonary hypertension in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis.
    Front Med (Lausanne). 2026;13:1889032.
    PubMed    
    Abstract available
    
    

88. LI J, Zisman LS, Cravets M, Aranda R, et al
    First-in-Human Safety and Pharmacokinetic Evaluation of Seralutinib, an Investigational Inhaled Tyrosine-protein Kinase Inhibitor for Pulmonary Hypertension.
    Pulm Pharmacol Ther. 2026 Oct 13:102453. doi: 10.1016/j.pupt.2026.102453.
    PubMed    
    Abstract available
    
    

89. KULA S, Karkin Tozlu G, Yurdaer M
    Evaluation of Pediatric Cardiologists' Knowledge Levels Regarding Pulmonary Hypertension: Commonly Misunderstood Concepts.
    Turk Kardiyol Dern Ars. 2026 Oct 13. doi: 10.5543/tkda.2026.13808.
    PubMed    
    Abstract available
    
    

90. BOTAN NI, Ahmed SI, Imaan FH, Madar KH, et al
    Advanced Rheumatic Heart Disease Complicated by Pregnancy, Mitral Valve Disease, Pulmonary Hypertension, and Left Atrial Thrombus: A Multidisciplinary Case Report from Resource-Limited Settings.
    Int Med Case Rep J. 2026;19:643597.
    PubMed    
    Abstract available
    
    

91. GOZDECKI L, Swat S, Kanwar M
    Beyond pulmonary hypertension: expanding the therapeutic frontier in chronic thromboembolic disease.
    J Thorac Dis. 2026;18:1078.
    PubMed    
    
    
    

92. LA B, Bai Y, Du Y, Qiu Y, et al
    Pressure-flow discordance in perioperative pulmonary hypertension: a mechanism-based review and provisional five-domain right-heart model for noncardiac surgery.
    Front Med (Lausanne). 2026;13:1972194.
    PubMed    
    Abstract available
    
    

93. HANYU N, Nara S, Nakayama T, Yamanaka G, et al
    A Case of Pulmonary Hypertensive Crisis Following Treatment of Retinopathy of Prematurity in an Extremely Preterm Infant.
    Pediatr Int. 2026;68:e70558.
    PubMed    
    
    
    

94. KAMIYA A, Minami M
    Effects of ONO-6950, a Novel Dual Cysteinyl Leukotriene 1 and 2 Receptor Antagonist, in a Rat Model of Pulmonary Arterial Hypertension.
    Biol Pharm Bull. 2026;49:1659-1666.
    PubMed    
    Abstract available
    
    

95. SINGH A, Prakash M, Hasija S, Makhija N, et al
    In Response to "Intravenous Levosimendan versus Milrinone: Coronary Sinus Lactate and PA Catheter Derived Parameters in Patients with Pulmonary Hypertension Undergoing Elective Mitral Valve Replacement".
    Ann Card Anaesth. 2026;29:663-664.
    PubMed    
    
    
    

96. AWAD AK, Chen J, Heresi GA, Kumar NS, et al
    Emergent Cervical Laminoplasty in a Patient with Chronic Thromboembolic Pulmonary Hypertension.
    Ann Card Anaesth. 2026;29:614-617.
    PubMed    
    Abstract available
    
    

97. DUBEY N, Singh S, Panchbhai P, Chaturvedi G, et al
    Oxidized mitochondrial DNA as a potential biomarker and mechanistic driver of autophagy-mitophagy dysregulation in pulmonary arterial hypertension: a narrative review.
    Mol Biol Rep. 2026;53:1716.
    PubMed    
    Abstract available
    
    

98. FAN T, Wang Y, Li L
    Alveolar macrophage heterogeneity in pulmonary hypertension: pathogenic mechanisms and precision intervention.
    J Hypertens. 2026 Oct 6. doi: 10.1097/HJH.0000000000004458.
    PubMed    
    Abstract available
    
    

99. LOZINA A, Maloir Q, Parzibut G, Gester F, et al
    [Pulmonary hypertension associated with interstitial lung diseases: current state of the art].
    Rev Med Liege. 2026;81:589-596.
    PubMed    
    Abstract available
    
    

100. LI J, Zhao J, Pang PP, Zhai WJ, et al
     Continuous Positive Airway Pressure Effects on Pulmonary Hemodynamics and Left Ventricular Function in Obstructive Sleep Apnea and Obesity Hypoventilation Syndrome: A Systematic Review and Meta-Analysis.
     Can Respir J. 2026;2026:e3020878.
     PubMed    
     Abstract available
     
     

101. XI Q, Liu H, Dai X, He J, et al
     Single-view echocardiography-based deep learning for pulmonary hypertension detection: a multi-level supervised and explainable approach.
     Quant Imaging Med Surg. 2026;16:774.
     PubMed    
     Abstract available
     
     

102. ZHANG R, Zhang Y, Li H, Zhang J, et al
     A single-cell census of pulmonary endarterectomies tissue across different anatomical regions in chronic thromboembolic pulmonary hypertension.
     Clin Transl Med. 2026;16:e70864.
     PubMed    
     Abstract available
     
     

103. HUAN C, Fu Z, Jiang R, Liu S, et al
     Mechanisms and Advances in the Treatment of Arrhythmias Associated With Pulmonary Hypertension.
     Rev Cardiovasc Med. 2026;27:52744.
     PubMed    
     Abstract available
     
     

104. LUO J, Liu J, Zhang H, Xin B, et al
     The critical role of NFAT transcription factors in pulmonary arterial remodeling and pulmonary hypertension: from PASMC proliferation to therapeutic targeting.
     Mol Biol Rep. 2026;53:1696.
     PubMed    
     Abstract available
     
     

105. MOHAMED E
     Persistent Pulmonary Hypertension of the Newborn: A Practical Review for UK Level 2 Local Neonatal Units.
     Cureus. 2026;18:e116003.
     PubMed    
     Abstract available
     
     

106. IKEMIYAGI H, Miyagi A, Nagata H, Shiohira S, et al
     Quantitative Inferior T-Wave Inversion as a Marker of High Pulmonary Vascular Resistance and All-Cause Mortality in Patients Evaluated for Pulmonary Hypertension.
     Pulm Circ. 2026;16:e70420.
     PubMed    
     Abstract available
     
     

107. NATOLI A, Reinhard B, Hallee L, Zhang H, et al
     VPS34 regulation in pulmonary arterial vascular smooth muscle cells in pulmonary hypertension.
     bioRxiv [Preprint]. 2026 Sep 29:2026.09.28.752142.
     PubMed    
     Abstract available
     
     

108. WANG C, Li Q, Zhang G, Yu Z, et al
     Interpretable machine learning-enabled risk stratification for pulmonary arterial hypertension associated with unrepaired congenital heart disease: results from a national prospective registry.
     Int J Cardiol. 2026;464:134779.
     PubMed    
     Abstract available
     
     

109. LI S, Yang M, Chen H, Chen S, et al
     FOXC1 drives pulmonary arterial endothelial cell dysfunction and vascular remodeling through transcriptional activation of MACC1.
     Free Radic Biol Med. 2026;256:423-440.
     PubMed    
     Abstract available
     
     

110. YAN D, Hu B, Jiang S, Zhang J, et al
     Cartilage oligomeric matrix protein in pulmonary arterial hypertension associated with lung adenocarcinoma.
     J Cardiothorac Surg. 2026;21:774.
     PubMed    
     Abstract available
     
     

111. LEIVA O, Liu OC, Ferrante M, Katsadouros VP, et al
     Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.
     Semin Hematol. 2026;63:110-117.
     PubMed    
     Abstract available
     
     

112. RICCIO AM, Feleke N, Palmer N, Jia L, et al
     Bridge to recovery: A case of V-V ECMO following V-A ECMO in Eisenmenger syndrome.
     Perfusion. 2026;41:1323-1326.
     PubMed    
     Abstract available
     
     

113. FUJIMOTO R, Usman A, Olia S, Spelde A, et al
     Use of veno-pulmoarterial ECMO to manage differential oxygenation in a lung transplant candidate.
     Perfusion. 2026;41:1307-1310.
     PubMed    
     Abstract available
     
     

114. CHEN Y, Wang X, Gao M, Zheng Q, et al
     Cellular Senescence and Vascular Ageing in Pulmonary Hypertension: Molecular Mechanisms, Therapeutic Strategies, and Translational Endpoints.
     Pulm Pharmacol Ther. 2026 Oct 23:102454. doi: 10.1016/j.pupt.2026.102454.
     PubMed    
     Abstract available
     
     

115. ITO N, Masuda T, Shimoji K, Yamaguchi K, et al
     Pulmonary diffusion capacity to select patients for echocardiographic evaluation of pulmonary hypertension in interstitial lung disease: Impact of interstitial lung disease phenotype.
     Respir Investig. 2026;64:101531.
     PubMed    
     Abstract available
     
     

116. REN J, Wang S, Ye C, Fan X, et al
     Ginsenoside compound K attenuates hypoxic pulmonary hypertension endothelial injury by suppressing POSTN-TrkB-mediated endothelial-mesenchymal transition.
     J Pharm Pharmacol. 2026;78:rgag125.
     PubMed    
     Abstract available
     
     

117. WHITEHEAD A, Berger R, Zhang Y, Ornoski O, et al
     Frespaciguat (MK-5475): A Novel Inhaled Soluble Guanylate Cyclase Stimulator for Pulmonary Hypertension Associated with COPD.
     J Med Chem. 2026;69:24182-24196.
     PubMed    
     Abstract available
     
     

118. DANH VD, Nguyen QQ, Nguyen HT
     Genetic Pulmonary Hypertension Combined With Biventricular Heart Failure: Role of AQP1 Gene Mutation.
     JACC Case Rep. 2026 Oct 22:110839. doi: 10.1016/j.jaccas.2026.110839.
     PubMed    
     Abstract available
     
     

119. WEN J, Yiminniyaze R, Li Y, Gong S, et al
     Right Ventricular-Pulmonary Arterial Coupling by Serial TAPSE/sPAP: A Noninvasive Predictor for Clinical Outcomes in Chronic Thromboembolic Pulmonary Hypertension.
     Pulm Circ. 2026;16:e70429.
     PubMed    
     Abstract available
     
     

120. USHIJIMA R, Imamura T, Hida Y, Ueno H, et al
     Reduction in Right Ventricular Stroke Work Index After Balloon Pulmonary Angioplasty is Associated With Long-Term Prognosis in Chronic Thromboembolic Pulmonary Hypertension.
     Pulm Circ. 2026;16:e70430.
     PubMed    
     Abstract available
     
     

121. WANG X, Han J, Yang S, Xiu M, et al
     FOXF1 and alveolar-vascular dysregulation in bronchopulmonary dysplasia-associated pulmonary hypertension.
     Front Physiol. 2026;17:1910923.
     PubMed    
     Abstract available
     
     

122. TAGER D, Bernardo RJ, Tonelli AR
     Pah in the era of obesity: navigating phenotypes of pulmonary hypertension.
     Expert Rev Respir Med. 2026 Oct 22. doi: 10.1080/17476348.2026.2753850.
     PubMed    
     Abstract available
     
     

123. HE M, Zhao Q, Xie H, Zhang R, et al
     Clinical, radiological, and pathological features of pulmonary hypertension associated with combined pulmonary fibrosis and emphysema.
     Respir Res. 2026;27:417.
     PubMed    
     Abstract available
     
     

124. MA W, Ma Y, Guo C, Su X, et al
     Lactylation modification: a new bridge connecting macrophage metabolism and pulmonary hypertension.
     Appl Microbiol Biotechnol. 2026;110:316.
     PubMed    
     Abstract available
     
     

125. ZHAO L, Hopley S, Chen CN, Kibreab I, et al
     Targeting ZIP12-mediated Zn(2+) signaling as a treatment for pulmonary hypertension.
     Sci Transl Med. 2026;18:eaee0680.
     PubMed    
     Abstract available
     
     

126. OREN MS, Lakshminrusimha S, Bautista L, Babata K, et al
     Systemic Arterial Blood Pressure Targets and Extracorporeal Membrane Oxygenation or Death in Persistent Pulmonary Hypertension of Newborns: A Cohort Analysis.
     Neonatology. 2026 Oct 21:1. doi: 10.1159.
     PubMed    
     Abstract available
     
     

127. WU P, Huan J, Liu C, Jin H, et al
     Key genes and pathways of pulmonary hypertension identified by integrating bulk and single-cell RNA sequencing.
     iScience. 2026;29:117846.
     PubMed    
     Abstract available
     
     

128. WANG P, Zhao F, Yang T, Yuan Y, et al
     Integrated multi-omics and machine learning identify core mechanobiology-associated immune genes in pulmonary arterial hypertension.
     Front Immunol. 2026;17:1867114.
     PubMed    
     Abstract available
     
     

129. KARAMPITSAKOS T, Wasserman E, Stagaki E, Thottassery A, et al
     Pulmonary hypertension optimal screening in interstitial lung disease (PHOS-ILD): a scoring system for the detection of pulmonary hypertension in patients with interstitial lung disease.
     Front Med (Lausanne). 2026;13:1908302.
     PubMed    
     Abstract available
     
     

130. STATTON B, Armour C, Leong K, Sedlacik J, et al
     4D-Flow MRI-Derived Wall Shear Stress as a Non-Invasive Biomarker for the Detection and Hemodynamic Characterization of Pulmonary Hypertension.
     Pulm Circ. 2026;16:e70426.
     PubMed    
     Abstract available
     
     

131. VENET M, Malik A, Gravinay P, Pradhan S, et al
     Right Ventricular Shear Wave Velocity Throughout the Cardiac Cycle in Pediatric Pulmonary Hypertension.
     Eur Heart J Cardiovasc Imaging. 2026 Oct 19:jeag291. doi: 10.1093.
     PubMed    
     
     
     

132. LTEIF C, Gawronski BE, Flohr RM, Mulligan RJ, et al
     beta3-Adrenergic Receptor Agonism Reduces Right Ventricular Systolic Pressure in a Preclinical Model of Heart Failure With Preserved Ejection Fraction-Associated Pulmonary Hypertension.
     J Cardiovasc Pharmacol Ther. 2026;31:10742484261495417.
     PubMed    
     Abstract available
     
     

133. ULRICH S, Milger K, Halank M, Klose H, et al
     Pulmonary hypertension associated with lung disease - an expert review from the Cologne Conference.
     Respiration. 2026 Oct 17:1. doi: 10.1159.
     PubMed    
     Abstract available
     
     

134. WANG H, Wang N, Ji Z, Zhang Y, et al
     Resolvin D1 attenuates pulmonary hypertension by suppressing pathological connexin 43-mediated gap junctional communication in pulmonary arterial smooth muscle cells.
     Front Pharmacol. 2026;17:1940174.
     PubMed    
     Abstract available
     
     

135. MA D, Shi L, Li C, Song D, et al
     KRIT1 Inhibits TGF-beta/Smad-Mediated Endothelial-To-Mesenchymal Transition in Pulmonary Arterial Hypertension.
     Clin Exp Pharmacol Physiol. 2026;53:e70161.
     PubMed    
     Abstract available
     
     

136. KOMORI T, Sato T, Yoshikawa S, Nakamura T, et al
     Prognostic impact of coexisting lung disease in patients with pulmonary arterial hypertension.
     Respir Med. 2026;263:109184.
     PubMed    
     Abstract available
     
     

137. BAI X, Tian K, Song S, Rao X, et al
     Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension with HADHA-associated improvements in fatty acid oxidation and mitochondrial redox homeostasis.
     Redox Biol. 2026;97:104392.
     PubMed    
     Abstract available
     
     

138. KHAN D, Matusov Y
     Global disparities in access to randomized controlled trials for pulmonary arterial hypertension.
     Respir Med. 2026;263:109165.
     PubMed    
     Abstract available
     
     

139. TONELLI AR, Aulak KS, Berro J, Highland KB, et al
     Activin pathway inhibition and rapid progression of malignancy in pulmonary arterial hypertension: A case series and hypothesis.
     Respir Med. 2026;263:109151.
     PubMed    
     Abstract available
     
     

140. LI J, Karoor V, Frump AL, Zhao H, et al
     Sexually Dimorphic Role of Estrogen Receptor alpha in Preserving Right Ventricular Endothelial Integrity.
     Arterioscler Thromb Vasc Biol. 2026;46:e325390.
     PubMed    
     Abstract available
     
     

141. RAZA F, Gregorich ZR, Freeman J, Moore B, et al
     Multimodal Framework of Left Heart-Pulmonary Vascular Remodeling Underlying Right Ventricular Failure in PH-HFpEF.
     Circ Heart Fail. 2026 Aug 24:e014620. doi: 10.1161/CIRCHEARTFAILURE.126.014620.
     PubMed    
     Abstract available
     
     

142. SIMPKIN CT, Taylor AC, MacLean J, Cookson M, et al
     Targeted Flow Cardiac MRI in Neonates with Intracardiac Shunts: A Novel Multi-Modality Imaging Approach to Hemodynamic Assessment.
     J Pediatr. 2026 Jul 23:115261. doi: 10.1016/j.jpeds.2026.115261.
     PubMed    
     Abstract available
     
     

143. SPALLA I, Bjerknaes MB, Bertuccini T, Menciotti G, et al
     A retrospective (2020-2025), multicenter study of myxomatous mitral valve disease in Chihuahuas from Italy, Sweden, and the United States of America.
     J Vet Cardiol. 2026;67:37-49.
     PubMed    
     Abstract available
     
     

144. GA Q, Xu Y, Zhou Y, Ge R, et al
     High-altitude adaptation and associated mortality risk in relocated Holstein cattle.
     J Dairy Sci. 2026;109:11934-11945.
     PubMed    
     Abstract available
     
     

145. PENA E, El Alam S, Hannemann J, Boger R, et al
     Compliance and Genetic Variability Are Determinants of the Success of l-Arginine/l-Citrulline Supplementation in High Altitude-A Pilot Study.
     High Alt Med Biol. 2026;27:245-253.
     PubMed    
     Abstract available
     
     

146. BRILLHART A, Enenbach M, Seufferheld J, Abramor B, et al
     Medical Screening of Climbers Who Later Develop High-Altitude Pulmonary Edema on Aconcagua.
     High Alt Med Biol. 2026;27:254-258.
     PubMed    
     Abstract available
     
     

147. DIK J, Topcuoglu C, Vardar-Yagli N, Goksuluk MB, et al
     The relationship between muscle strength and oxygenation and activities of daily living in adolescents and young adults with pulmonary arterial hypertension.
     Cardiol Young. 2026;36:150-156.
     PubMed    
     Abstract available
     
     

148. PATSIOU V, Grantza T, Chrysochoidis-Trantas T, Kavga M, et al
     Efficacy and Tolerability of Selexipag in Pediatric Patients with Pulmonary Arterial Hypertension: An Updated Systematic Review and Meta-analysis.
     Pediatr Cardiol. 2026;47:3233-3243.
     PubMed    
     Abstract available
     
     

149. BENLI O, Kasap MK, Topcuoglu MS
     A rare case: adult cor triatriatum sinister with tricuspid regurgitation.
     Cardiol Young. 2025;35:1305-1307.
     PubMed    
     Abstract available
     
     

150. FABIANI N, Heath-Freudenthal A, Von Alvensleben I, Echazu G, et al
     Use of a ductal occluder device as a test and then permanent closure of a large ductus arteriosus with increased pulmonary vascular resistance: a case report.
     Cardiol Young. 2025;35:1283-1286.
     PubMed    
     Abstract available
     
     

151. RIDEB J, Bikou O, Watanabe K, Mazurek R, et al
     Pulmonary Hypertension Increases Left Ventricular Chamber Stiffness Through Ventricular Interdependence and Is Attenuated by Pulmonary-Targeted SERCA2a Gene Therapy.
     Am J Physiol Heart Circ Physiol. 2026 Oct 7. doi: 10.1152/ajpheart.90090.2026.
     PubMed    
     Abstract available
     
     

152. SKAUG B, Rodolfi S, Denton CP, Shah AA, et al
     Pulmonary arterial hypertension susceptibility and mortality among patients with systemic sclerosis with the DNASE1L3 rs35677470 (Arg206Cys) variant.
     Ann Rheum Dis. 2026;85:2014-2021.
     PubMed    
     Abstract available
     
     

153. XU P, Li XL, Wang XQ
     Unstable Reference and Unblinded Comparison Undermine Artificial Intelligence Echocardiography in Pulmonary Hypertension.
     Chest. 2026;170:e138-e139.
     PubMed    
     
     
     

154. JOHNSON SW, Zeder K
     Deconstructing Heterogeneity of Pulmonary Hypertension Associated With Chronic Lung Disease with Quantitative Chest CT Data.
     Chest. 2026;170:1006-1008.
     PubMed    
     
     
     

155. CRITSER PJ, Krishnan US, Avitabile CM, Jones AL, et al
     Sotatercept in Pediatric Pulmonary Hypertension: Experience from the Pediatric Pulmonary Hypertension Network.
     Chest. 2026 Oct 5:S0012-3692(26)06787-5. doi: 10.1016/j.chest.2026.
     PubMed    
     Abstract available
     
     

156. SULICA R, De Marco T, Elwing JM, Bartolome S, et al
     Managing a Critically Ill Patient With Pulmonary Arterial Hypertension.
     Chest. 2026;170:1260-1271.
     PubMed    
     Abstract available
     
     

157. LACOSTE-PALASSET T, Baron A, Ebstein N, Beurnier A, et al
     Impact of Pulmonary Arterial Hypertension Therapies on Gas Exchange in Portopulmonary Hypertension.
     Chest. 2026;170:1205-1217.
     PubMed    
     Abstract available
     
     

158. VIRK ST, Bryant AJ
     Deus Ex Mechano: Hydrostatic Pressure in Pulmonary Hypertension.
     Circ Res. 2026;139:e329683.
     PubMed    
     
     
     

159. JIANG X, Ma L, Li Y, Deng X, et al
     Pathogenic B-T Cell Axis Driven by BAFF Induces Endothelial Apoptosis in SLE-PAH.
     Circ Res. 2026;139:e328338.
     PubMed    
     Abstract available
     
     

160. MORGAN CE, Levy PT, Mullen MP, Abman SH, et al
     A novel multidimensional classification for neonatal pulmonary hypertension: a viewpoint.
     Eur Respir J. 2026 Oct 23:2600986. doi: 10.1183/13993003.00986-2026.
     PubMed    
     
     
     

161. ZEDER K, Yin Y, Maron BA
     Reply to: From missing mPAP to clinical implementation: does automated imputation reveal missed pulmonary hypertension?
     Eur Respir J. 2026;68:2601698.
     PubMed    
     
     
     

162. NASCIMENTO I, Gomes Carvalho G, Dos Santos Fernandes CJC
     From missing mPAP to clinical implementation: does automated imputation reveal missed pulmonary hypertension?
     Eur Respir J. 2026;68:2601564.
     PubMed    
     
     
     

163. WANG Q, Liang F, Du S, Li Q, et al
     Long-term Exposure to PM(2.5) and Risk of Adverse Pregnancy Events in Women with Pulmonary Hypertension: A Nationwide Multicenter Study.
     J Heart Lung Transplant. 2026 Sep 29:S1053-2498(26)02108.
     PubMed    
     Abstract available
     
     

164. BROWNSTEIN AJ, Shaikh F, Xiao GQ, Wilhalme H, et al
     "Interstitial lung disease with associated severe pulmonary hypertension is rarely idiopathic by clinical or pathologic measures".
     J Heart Lung Transplant. 2026 Oct 10:S1053-2498(26)02135.
     PubMed    
     Abstract available
     
     

165. LI D, Yao M, Shi H, Jia C, et al
     Noninvasive oxygenation monitoring in PPHN: validation of the oxygen saturation index and the oxygen saturation to fraction of inspired oxygen ratio against conventional invasive indices.
     J Perinatol. 2026;46:1887-1893.
     PubMed    
     Abstract available
     
     

166. AMELIA P, Sahertian LCD, Adriansyah R, Kannady J, et al
     Nutritional status, clinical burden, and healthcare utilization among pediatric outpatients with congenital heart disease: A retrospective cross-sectional study from Indonesia.
     PLoS One. 2026;21:e0351014.
     PubMed    
     Abstract available